Analyze Diet
The open microbiology journal2010; 4; 20-25; doi: 10.2174/1874285801004010020

IgG Endopeptidase SeMac does not Inhibit Opsonophagocytosis of Streptococcus equi Subspecies equi by Horse Polymorphonuclear Leukocytes.

Abstract: The secreted Mac protein made by group A Streptococcus (GAS) inhibits opsonophagocytosis of GAS by human polymorphonuclear leukocytes (PMNs). This protein also has the endopeptidase activity against human immunoglobulin G (IgG), and the Cys94, His262 and Asp284 are critical for the enzymatic activity. The horse pathogen Streptococcus equi subspecies equi produces a homologue of Mac (SeMac). SeMac was characterized to determine whether SeMac has IgG endopeptidase activity and inhibits opsonophagocytosis of S. equi by horse PMNs. The gene was cloned and recombinant SeMac was overexpressed in Escherichia coli and purified to homogeneity. Mice with experimental S. equi infection and horses with strangles caused by S. equi seroconverted to SeMac, indicating that SeMac is produced in vivo during infection. SeMac has endopeptidase activity against human IgG. However, the protein just cleaves a small fraction, which may be IgG1 only, of horse IgG. Replacement of Cys102 with Ser or His272 with Ala abolishes the enzymatic activity of SeMac, and the Asp294Ala mutation greatly decreases the enzymatic activity. SeMac does not inhibit opsonophagocytosis of S. equi by horse PMNs but opsonophagocytosis of GAS by human PMNs. Thus, SeMac is a cysteine endopeptidase with a limited activity against horse IgG and must have other function.
Publication Date: 2010-04-08 PubMed ID: 20556207PubMed Central: PMC2885601DOI: 10.2174/1874285801004010020Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates whether the SeMac protein, produced by a horse pathogen, possesses endopeptidase activity, and if it can inhibit the process in which horse immune cells (PMNs) swallow and destroy certain bacterial pathogens. They found that SeMac does have this activity against antibodies in humans but has limited effectiveness against horse antibodies. Furthermore, it does not stop horse PMNs from destroying the bacteria.

Study Methods and Findings

  • The protein SeMac, produced by the horse pathogen Streptococcus equi, was studied to understand if it has immunoglobulin G (IgG) endopeptidase activity and whether it could inhibit a process called opsonophagocytosis in horse PMNs (a type of immune cell).
  • Researchers cloned the gene which codes for SeMac and overexpressed it in E. coli bacteria, effectively producing a large quantity of the protein for study.
  • They found that mice and horses infected with S. equi produced antibodies against SeMac, confirming that it is indeed active during infections.
  • SeMac demonstrated endopeptidase activity against human IgG, meaning it is capable of breaking down these antibodies. However, it only seemed to break down a small fraction of horse IgG and was less active.
  • When important amino acids in SeMac (Cys102 and His272) were replaced, the enzyme lose its ability to break down antibodies, suggesting these parts are crucial for its function.

Implications and Further Findings

  • Notably, SeMac did not inhibit the ability of horse PMNs to undergo opsonophagocytosis of S. equi. In fact, SeMac only inhibited opsonophagocytosis of group A Streptococcus (GAS) by human PMNs.
  • In other words, while SeMac can break down some human antibodies and potentially interfere with human immune responses to GAS, it was less effective against horse antibodies and did not interfere with the horse immune response to S. equi.
  • Given its limited activity against horse IgG and its inability to inhibit horse opsonophagocytosis, researchers suggest that SeMac likely has other functions in the infection process that are not yet understood.
  • This finding helps in understanding the precise roles of bacterial proteins in the infection process and may aid future therapeutic strategies against S. equi and similar pathogens.

Cite This Article

APA
Liu M, Lei B. (2010). IgG Endopeptidase SeMac does not Inhibit Opsonophagocytosis of Streptococcus equi Subspecies equi by Horse Polymorphonuclear Leukocytes. Open Microbiol J, 4, 20-25. https://doi.org/10.2174/1874285801004010020

Publication

ISSN: 1874-2858
NlmUniqueID: 101480482
Country: United Arab Emirates
Language: English
Volume: 4
Pages: 20-25

Researcher Affiliations

Liu, Mengyao
  • Department of Veterinary Molecular Biology, Montana State University, Bozeman, Montana 59717, USA.
Lei, Benfang

    Grant Funding

    • P20 RR020185 / NCRR NIH HHS

    References

    This article includes 20 references
    1. Timoney JF. Strangles.. Vet Clin North Am Equine Pract 1993 Aug;9(2):365-74.
      pubmed: 8358649doi: 10.1016/s0749-0739(17)30403-0google scholar: lookup
    2. Harrington DJ, Sutcliffe IC, Chanter N. The molecular basis of Streptococcus equi infection and disease.. Microbes Infect 2002 Apr;4(4):501-10.
      pubmed: 11932201doi: 10.1016/s1286-4579(02)01565-4google scholar: lookup
    3. Woolcock JB. Immunity to Streptococcus equi.. Aust Vet J 1975 Dec;51(12):554-9.
    4. Timoney JF, Eggers D. Serum bactericidal responses to Streptococcus equi of horses following infection or vaccination.. Equine Vet J 1985 Jul;17(4):306-10.
    5. Lei B, DeLeo FR, Hoe NP, Graham MR, Mackie SM, Cole RL, Liu M, Hill HR, Low DE, Federle MJ, Scott JR, Musser JM. Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis.. Nat Med 2001 Dec;7(12):1298-305.
      pubmed: 11726969doi: 10.1038/nm1201-1298google scholar: lookup
    6. von Pawel-Rammingen U, Johansson BP, Björck L. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G.. EMBO J 2002 Apr 2;21(7):1607-15.
      pmc: PMC125946pubmed: 11927545doi: 10.1093/emboj/21.7.1607google scholar: lookup
    7. Lei B, DeLeo FR, Reid SD, Voyich JM, Magoun L, Liu M, Braughton KR, Ricklefs S, Hoe NP, Cole RL, Leong JM, Musser JM. Opsonophagocytosis-inhibiting mac protein of group a streptococcus: identification and characteristics of two genetic complexes.. Infect Immun 2002 Dec;70(12):6880-90.
    8. Lei B, Liu M, Meyers EG, Manning HM, Nagiec MJ, Musser JM. Histidine and aspartic acid residues important for immunoglobulin G endopeptidase activity of the group A Streptococcus opsonophagocytosis-inhibiting Mac protein.. Infect Immun 2003 May;71(5):2881-4.
    9. Agniswamy J, Lei B, Musser JM, Sun PD. Insight of host immune evasion mediated by two variants of group a Streptococcus Mac protein.. J Biol Chem 2004 Dec 10;279(50):52789-96.
      pubmed: 15466462doi: 10.1074/jbc.M410698200google scholar: lookup
    10. Liu M, McClure MJ, Zhu H, Xie G, Lei B. The Two-Component Regulatory System VicRK is Important to Virulence of Streptococcus equi Subspecies equi.. Open Microbiol J 2008;2:89-93.
      pmc: PMC2593050pubmed: 19088917doi: 10.2174/1874285800802010089google scholar: lookup
    11. Hoe N, Nakashima K, Grigsby D, Pan X, Dou SJ, Naidich S, Garcia M, Kahn E, Bergmire-Sweat D, Musser JM. Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains.. Emerg Infect Dis 1999 Mar-Apr;5(2):254-63.
      pmc: PMC2640708pubmed: 10221878doi: 10.3201/eid0502.990210google scholar: lookup
    12. Holden MT, Heather Z, Paillot R, Steward KF, Webb K, Ainslie F, Jourdan T, Bason NC, Holroyd NE, Mungall K, Quail MA, Sanders M, Simmonds M, Willey D, Brooks K, Aanensen DM, Spratt BG, Jolley KA, Maiden MC, Kehoe M, Chanter N, Bentley SD, Robinson C, Maskell DJ, Parkhill J, Waller AS. Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens.. PLoS Pathog 2009 Mar;5(3):e1000346.
    13. White-Owen C, Alexander JW, Sramkoski RM, Babcock GF. Rapid whole-blood microassay using flow cytometry for measuring neutrophil phagocytosis.. J Clin Microbiol 1992 Aug;30(8):2071-6.
    14. Liu M, Hanks TS, Zhang J, McClure MJ, Siemsen DW, Elser JL, Quinn MT, Lei B. Defects in ex vivo and in vivo growth and sensitivity to osmotic stress of group A Streptococcus caused by interruption of response regulator gene vicR.. Microbiology (Reading) 2006 Apr;152(Pt 4):967-978.
      pmc: PMC2423276pubmed: 16549661doi: 10.1099/mic.0.28706-0google scholar: lookup
    15. Xie G, Liu M, Zhu H, Lei B. Esterase SeE of Streptococcus equi ssp. equi is a novel nonspecific carboxylic ester hydrolase.. FEMS Microbiol Lett 2008 Dec;289(2):181-6.
    16. Lei B, Mackie S, Lukomski S, Musser JM. Identification and immunogenicity of group A Streptococcus culture supernatant proteins.. Infect Immun 2000 Dec;68(12):6807-18.
    17. Wagner B. Immunoglobulins and immunoglobulin genes of the horse.. Dev Comp Immunol 2006;30(1-2):155-64.
      pubmed: 16046236doi: 10.1016/j.dci.2005.06.008google scholar: lookup
    18. Lannergård J, Guss B. IdeE, an IgG-endopeptidase of Streptococcus equi ssp. equi.. FEMS Microbiol Lett 2006 Sep;262(2):230-5.
    19. Timoney JF, Yang J, Liu J, Merant C. IdeE reduces the bactericidal activity of equine neutrophils for Streptococcus equi.. Vet Immunol Immunopathol 2008 Mar 15;122(1-2):76-82.
      pubmed: 18077002doi: 10.1016/j.vetimm.2007.10.017google scholar: lookup
    20. Heath A, DiRita VJ, Barg NL, Engleberg NC. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B.. Infect Immun 1999 Oct;67(10):5298-305.

    Citations

    This article has been cited 1 times.
    1. Lei B. Benfang Lei's research on heme acquisition in Gram-positive pathogens and bacterial pathogenesis.. World J Biol Chem 2010 Sep 26;1(9):286-90.
      doi: 10.4331/wjbc.v1.i9.286pubmed: 21537486google scholar: lookup